This article explains how to interpret an FDA Form 483 and Warning Letter, identify underlying causes, and develop an effective remediation strategy. It emphasizes the importance of timely, well-documented corrective action and provides practical guidance for addressing inspectional observations.

An FDA inspection doesn't have to be daunting. Our step-by-step guide provides a roadmap for proactive preparation, covering everything from QMS review to effective FDA-483 responses. By taking a proactive approach, you can ensure your team is ready for a successful inspection outcome.

Download this poster to explore how evolving global guidance is shaping the future of auditing, including risk-based approaches, updated SOPs, and technology-driven practices.

Despite similarities and differences in their roles, both auditors and inspectors play an important part in ensuring compliance.

Explore the benefits of on-the-job training for Clinical Research Professionals

This downloadable poster elaborates on the problems surrounding education bias in the biopharmaceutical industry.

This downloadable poster presents the clear steps of how to become a consultant while evaluating if consultancy is the best fit for someone’s experience and career goals.

First presented at SQA 2022 FDAQRC’s Project Manager, Amanda White examines how poor-quality culture can take a toll on your organization.